Boston Scientific Corp (BSX) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.

Total Assets Chart for Boston Scientific Corp

Boston Scientific Corp (BSX) total assets for FY2025 were USD 43.7B, a 10.9% change from FY2024. Boston Scientific Corp's total assets grew from USD 137.4M in 1991 to USD 43.7B in 2025 (31685.3% over 34 years). Total assets compound annual growth rate: 5-year CAGR of 7.2%, 10-year CAGR of 9.2%, 20-year CAGR of 8.7%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$61.87B
Implied Share Price
$42.69
Enterprise Value
$73.58B
Revenue (TTM)
$21.07B
EBITDA
$5.77B
Profit Margin
16.62%
Trailing P/E
18.01
Forward P/E
12.58
Price/Book (MRQ)
2.47
Price/Sales (TTM)
2.94
EV/EBITDA
14.84
EV/Revenue
3.49
Dividend Yield
—
Book Value
$16.34
Free Cash Flow (FY2025)
$3.66B
Free Cash Flow Yield
5.91%

Snapshot as of 30th October 2026 — not point-in-time controlled, may lag the live market by a few days.